332 
Secretary shall submit to Congress a report on the use 
of funds provided pursuant to this part. 
‘‘(b) REPORT ON IMPACT OF PROGRAMS.—Not later 
than March 1, 2019, the Secretary shall submit to Con-
gress a report on the impact of the programs under this 
part on reducing unintended teenage pregnancies. 
‘‘SEC. 399OO–9. AUTHORIZATION OF APPROPRIATIONS. 
‘‘(a) IN GENERAL.—There are authorized to be ap-
propriated to carry out this part such sums as may be 
necessary for each of the fiscal years 2015 through 2019. 
‘‘(b) AVAILABILITY.—Amounts appropriated pursu-
ant to subsection (a)— 
‘‘(1) are authorized to remain available until ex-
pended; and 
‘‘(2) are in addition to amounts otherwise made 
available for such purposes.’’. 
SEC. 509. GESTATIONAL DIABETES. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by adding after section 
317H the following: 
‘‘SEC. 317H–1. GESTATIONAL DIABETES. 
‘‘(a) UNDERSTANDING
AND MONITORING GESTA-
TIONAL DIABETES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00332
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
333 
Control and Prevention, in consultation with the Di-
abetes Mellitus Interagency Coordinating Committee 
established under section 429 and representatives of 
appropriate national health organizations, shall de-
velop a multisite gestational diabetes research 
project within the diabetes program of the Centers 
for Disease Control and Prevention to expand and 
enhance surveillance data and public health research 
on gestational diabetes. 
‘‘(2) AREAS TO BE ADDRESSED.—The research 
project developed under paragraph (1) shall ad-
dress— 
‘‘(A) procedures to establish accurate and 
efficient systems for the collection of gestational 
diabetes data within each State and common-
wealth, territory, or possession of the United 
States; 
‘‘(B) the progress of collaborative activities 
with the National Vital Statistics System, the 
National Center for Health Statistics, and 
State health departments with respect to the 
standard birth certificate, in order to improve 
surveillance of gestational diabetes; 
‘‘(C) postpartum methods of tracking 
women with gestational diabetes after delivery 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00333
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
334 
as well as targeted interventions proven to 
lower the incidence of type 2 diabetes in that 
population; 
‘‘(D) variations in the distribution of diag-
nosed and undiagnosed gestational diabetes, 
and of impaired fasting glucose tolerance and 
impaired fasting glucose, within and among 
groups of women; and 
‘‘(E) factors and culturally sensitive inter-
ventions that influence risks and reduce the in-
cidence of gestational diabetes and related com-
plications during childbirth, including cultural, 
behavioral, racial, ethnic, geographic, demo-
graphic, socioeconomic, and genetic factors. 
‘‘(3) REPORT.—Not later than 2 years after the 
date of the enactment of this section, and annually 
thereafter, the Secretary shall generate a report on 
the findings and recommendations of the research 
project including prevalence of gestational diabetes 
in the multisite area and disseminate the report to 
the appropriate Federal and non-Federal agencies. 
‘‘(b) EXPANSION OF GESTATIONAL DIABETES RE-
SEARCH.— 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00334
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
335 
‘‘(1) IN GENERAL.—The Secretary shall expand 
and intensify public health research regarding gesta-
tional diabetes. Such research may include— 
‘‘(A) developing and testing novel ap-
proaches for improving postpartum diabetes 
testing or screening and for preventing type 2 
diabetes in women with a history of gestational 
diabetes; and 
‘‘(B) conducting public health research to 
further understanding of the epidemiologic, 
socioenvironmental, behavioral, translation, and 
biomedical factors and health systems that in-
fluence the risk of gestational diabetes and the 
development of type 2 diabetes in women with 
a history of gestational diabetes. 
‘‘(2) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated to carry out 
this subsection $5,000,000 for each of fiscal years 
2015 through 2019. 
‘‘(c) DEMONSTRATION GRANTS TO LOWER
THE 
RATE OF GESTATIONAL DIABETES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall award grants, on a 
competitive basis, to eligible entities for demonstra-
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00335
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
336 
tion projects that implement evidence-based inter-
ventions to reduce the incidence of gestational diabe-
tes, the recurrence of gestational diabetes in subse-
quent pregnancies, and the development of type 2 di-
abetes in women with a history of gestational diabe-
tes. 
‘‘(2) PRIORITY.—In making grants under this 
subsection, the Secretary shall give priority to 
projects focusing on— 
‘‘(A) helping women who have 1 or more 
risk factors for developing gestational diabetes; 
‘‘(B) working with women with a history of 
gestational diabetes during a previous preg-
nancy; 
‘‘(C) providing postpartum care for women 
with gestational diabetes; 
‘‘(D) tracking cases where women with a 
history of gestational diabetes developed type 2 
diabetes; 
‘‘(E) educating mothers with a history of 
gestational diabetes about the increased risk of 
their child developing diabetes; 
‘‘(F) working to prevent gestational diabe-
tes and prevent or delay the development of 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00336
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
337 
type 2 diabetes in women with a history of ges-
tational diabetes; and 
‘‘(G) achieving outcomes designed to assess 
the efficacy and cost-effectiveness of interven-
tions that can inform decisions on long-term 
sustainability, including third-party reimburse-
ment. 
‘‘(3) APPLICATION.—An eligible entity desiring 
to receive a grant under this subsection shall submit 
to the Secretary— 
‘‘(A) an application at such time, in such 
manner, and containing such information as the 
Secretary may require; and 
‘‘(B) a plan to— 
‘‘(i) lower the rate of gestational dia-
betes during pregnancy; or 
‘‘(ii) develop methods of tracking 
women with a history of gestational diabe-
tes and develop effective interventions to 
lower the incidence of the recurrence of 
gestational diabetes in subsequent preg-
nancies and the development of type 2 dia-
betes. 
‘‘(4) USES OF FUNDS.—An eligible entity re-
ceiving a grant under this subsection shall use the 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00337
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
339 
in the practice settings of the health care 
providers. 
‘‘(5) REPORT.—Not later than 4 years after the 
date of the enactment of this section, the Secretary 
shall prepare and submit to the Congress a report 
concerning the results of the demonstration projects 
conducted through the grants awarded under this 
subsection. 
‘‘(6) DEFINITION
OF
ELIGIBLE
ENTITY.—In 
this subsection, the term ‘eligible entity’ means a 
nonprofit organization (such as a nonprofit academic 
center or community health center) or a State, trib-
al, or local health agency. 
‘‘(7) AUTHORIZATION
OF
APPROPRIATIONS.— 
There is authorized to be appropriated to carry out 
this subsection $5,000,000 for each of fiscal years 
2015 through 2019. 
‘‘(d) POSTPARTUM FOLLOWUP REGARDING GESTA-
TIONAL DIABETES.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall work with the State- and tribal-based diabetes 
prevention and control programs assisted by the Centers 
to encourage postpartum followup after gestational diabe-
tes, as medically appropriate, for the purpose of reducing 
the incidence of gestational diabetes, the recurrence of 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00339
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
340 
gestational diabetes in subsequent pregnancies, the devel-
opment of type 2 diabetes in women with a history of ges-
tational diabetes, and related complications.’’. 
SEC. 510. EMERGENCY CONTRACEPTION EDUCATION AND 
INFORMATION PROGRAMS. 
(a) EMERGENCY
CONTRACEPTION
PUBLIC
EDU-
CATION PROGRAM.— 
(1) 
IN
GENERAL.—The 
Secretary, 
acting 
through the Director of the Centers for Disease 
Control and Prevention, shall develop and dissemi-
nate to the public information on emergency contra-
ception. 
(2) DISSEMINATION.—The Secretary may dis-
seminate information under paragraph (1) directly 
or through arrangements with nonprofit organiza-
tions, consumer groups, institutions of higher edu-
cation, clinics, the media, and Federal, State, and 
local agencies. 
(3) INFORMATION.—The information dissemi-
nated under paragraph (1) shall include, at a min-
imum, a description of emergency contraception and 
an explanation of the use, safety, efficacy, and avail-
ability of such contraception. 
(b) EMERGENCY
CONTRACEPTION
INFORMATION 
PROGRAM FOR HEALTH CARE PROVIDERS.— 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00340
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
341 
(1) 
IN
GENERAL.—The 
Secretary, 
acting 
through the Administrator of the Health Resources 
and Services Administration and in consultation 
with major medical and public health organizations, 
shall develop and disseminate to health care pro-
viders information on emergency contraception. 
(2) INFORMATION.—The information dissemi-
nated under paragraph (1) shall include, at a min-
imum— 
(A) information describing the use, safety, 
efficacy, and availability of emergency contra-
ception; 
(B) a recommendation regarding the use of 
such contraception in appropriate cases; and 
(C) information explaining how to obtain 
copies of the information developed under sub-
section (a) for distribution to the patients of 
the providers. 
(c) DEFINITIONS.—In this section: 
(1) EMERGENCY
CONTRACEPTION.—The term 
‘‘emergency contraception’’ means a drug or device 
(as the terms are defined in section 201 of the Fed-
eral Food, Drug, and Cosmetic Act (21 U.S.C. 321)) 
or a drug regimen that— 
(A) is used postcoitally; 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00341
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
342 
(B) prevents pregnancy primarily by pre-
venting or delaying ovulation, and does not ter-
minate an established pregnancy; and 
(C) is approved by the Food and Drug Ad-
ministration. 
(2) HEALTH
CARE
PROVIDER.—The term 
‘‘health care provider’’ means an individual who is li-
censed or certified under State law to provide health 
care services and who is operating within the scope 
of such license. Such term shall include a phar-
macist. 
(3) INSTITUTION OF HIGHER EDUCATION.—The 
term ‘‘institution of higher education’’ has the same 
meaning given such term in section 101(a) of the 
Higher Education Act of 1965 (20 U.S.C. 1001(a)). 
(4) SECRETARY.—The term ‘‘Secretary’’ means 
the Secretary of Health and Human Services. 
(d) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary for each of the fiscal years 
2015 through 2019. 
SEC. 511. SUPPORTING HEALTHY ADOLESCENT DEVELOP-
MENT. 
(a) IN GENERAL.—The Secretary may award a grant 
to each eligible State to conduct programs of sex education 
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00342
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS
343 
described in subsection (b), including education on both 
abstinence and contraception for the prevention of teenage 
pregnancy and sexually transmitted diseases, including 
HIV/AIDS and viral hepatitis. 
(b) REQUIREMENTS
FOR SEX EDUCATION PRO-
GRAMS.—A program of sex education described in this 
subsection is a program that— 
(1) is age appropriate and medically accurate; 
(2) stresses the value of abstinence while not ig-
noring those young people who have been or are sex-
ually active; 
(3) includes information providing a factual un-
derstanding of male and female reproductive anat-
omy; 
(4) provides information about the health bene-
fits and side effects of contraceptive and barrier 
methods used— 
(A) as a means to prevent pregnancy; and 
(B) to reduce the risk of contracting sexu-
ally transmitted disease, including HIV/AIDS 
and viral hepatitis; 
(5) encourages family communication between 
parent and child about sexuality; 
(6) cultivates a respectful dialogue about sexu-
ality, including sexual orientation and gender iden-
VerDate Mar 15 2010 
23:38 Aug 05, 2014
Jkt 039200
PO 00000
Frm 00343
Fmt 6652
Sfmt 6201
E:\BILLS\H5294.IH
H5294
smartinez on DSK4TPTVN1PROD with BILLS